Department of Cell and Developmental Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Mol Biol Cell. 2011 Feb 1;22(3):301-14. doi: 10.1091/mbc.E10-09-0760. Epub 2010 Dec 9.
Relative contributions of folding kinetics versus protein quality control (QC) activity in the partitioning of non-native proteins between life and death are not clear. Cystic fibrosis transmembrane conductance regulator (CFTR) biogenesis serves as an excellent model to study this question because folding of nascent CFTR is inefficient and deletion of F508 causes accumulation of CFTRΔF508 in a kinetically trapped, but foldable state. Herein, a novel endoplasmic reticulum (ER)-associated Hsp40, DNAJB12 (JB12) is demonstrated to play a role in control of CFTR folding efficiency. JB12 cooperates with cytosolic Hsc70 and the ubiquitin ligase RMA1 to target CFTR and CFTRΔF508 for degradation. Modest elevation of JB12 decreased nascent CFTR and CFTRΔF508 accumulation while increasing association of Hsc70 with ER forms of CFTR and the RMA1 E3 complex. Depletion of JB12 increased CFTR folding efficiency up to threefold and permitted a pool of CFTRΔF508 to fold and escape the ER. Introduction of the V510D misfolding suppressor mutation into CFTRΔF508 modestly increased folding efficiency, whereas combined inactivation of JB12 and suppression of intrinsic folding defects permitted CFTRΔF508 to fold at 50% of wild-type efficiency. Therapeutic correction of CFTRΔF508 misfolding in cystic fibrosis patients may require repair of defective folding kinetics and suppression of ER QC factors, such as JB12.
新生 CFTR 折叠效率低,F508 缺失导致 CFTRΔF508 以动力学捕获但可折叠的状态积聚,因此囊性纤维化跨膜电导调节因子 (CFTR) 的生物发生可作为研究这一问题的理想模型。本文证明,一种新型内质网 (ER) 相关 Hsp40,即 DNAJB12 (JB12),在控制 CFTR 折叠效率方面发挥作用。JB12 与胞质 Hsc70 和泛素连接酶 RMA1 合作,靶向 CFTR 和 CFTRΔF508 进行降解。JB12 的适度升高可减少新生 CFTR 和 CFTRΔF508 的积累,同时增加 Hsc70 与 CFTR 的 ER 形式和 RMA1 E3 复合物的结合。JB12 的耗竭可将 CFTR 折叠效率提高至三倍,并使 CFTRΔF508 折叠并逃离 ER。将 V510D 错折叠抑制突变引入 CFTRΔF508 可适度提高折叠效率,而 JB12 的失活和内在折叠缺陷的抑制相结合可使 CFTRΔF508 以野生型效率的 50%折叠。囊性纤维化患者 CFTRΔF508 错折叠的治疗校正可能需要修复有缺陷的折叠动力学并抑制 ER QC 因子,如 JB12。